JP2008537110A5 - - Google Patents

Download PDF

Info

Publication number
JP2008537110A5
JP2008537110A5 JP2008504212A JP2008504212A JP2008537110A5 JP 2008537110 A5 JP2008537110 A5 JP 2008537110A5 JP 2008504212 A JP2008504212 A JP 2008504212A JP 2008504212 A JP2008504212 A JP 2008504212A JP 2008537110 A5 JP2008537110 A5 JP 2008537110A5
Authority
JP
Japan
Prior art keywords
general formula
compound
immunoassay
antibody
immunoassay method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008504212A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008537110A (ja
JP4896959B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/011022 external-priority patent/WO2006104970A1/en
Publication of JP2008537110A publication Critical patent/JP2008537110A/ja
Publication of JP2008537110A5 publication Critical patent/JP2008537110A5/ja
Application granted granted Critical
Publication of JP4896959B2 publication Critical patent/JP4896959B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008504212A 2005-03-30 2006-03-27 ドキソルビシン免疫測定法 Expired - Fee Related JP4896959B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66628805P 2005-03-30 2005-03-30
US60/666,288 2005-03-30
PCT/US2006/011022 WO2006104970A1 (en) 2005-03-30 2006-03-27 Doxorubicin immunoassay

Publications (3)

Publication Number Publication Date
JP2008537110A JP2008537110A (ja) 2008-09-11
JP2008537110A5 true JP2008537110A5 (enExample) 2009-05-21
JP4896959B2 JP4896959B2 (ja) 2012-03-14

Family

ID=37053697

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008504212A Expired - Fee Related JP4896959B2 (ja) 2005-03-30 2006-03-27 ドキソルビシン免疫測定法

Country Status (9)

Country Link
US (5) US7569358B2 (enExample)
EP (2) EP2239573A3 (enExample)
JP (1) JP4896959B2 (enExample)
AT (1) ATE476655T1 (enExample)
CA (1) CA2602849C (enExample)
DE (1) DE602006015929D1 (enExample)
DK (1) DK1864129T3 (enExample)
ES (1) ES2353212T3 (enExample)
WO (1) WO2006104970A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2602849C (en) * 2005-03-30 2013-06-04 Saladax Biomedical Inc. Doxorubicin immunoassay
US8076097B2 (en) * 2009-08-19 2011-12-13 Saladax Biomedical Inc. Imatinib immunoassay
US20110165699A1 (en) * 2009-12-08 2011-07-07 Salamone Salvatore J Irinotecan immunoassay
US20110136253A1 (en) * 2009-12-08 2011-06-09 Salamone Salvatore J Irinotecan Immunoassay
US8114621B2 (en) * 2010-03-12 2012-02-14 Saladax Biomedical Inc. Lenalidomide and thalidomide immunoassays
US8088594B2 (en) * 2010-03-16 2012-01-03 Saladax Biomedical Inc. Risperidone immunoassay
WO2012067670A1 (en) * 2010-11-18 2012-05-24 Saladax Biomedical Inc. Irinotecan immunoassay
US8426143B2 (en) 2011-05-24 2013-04-23 Saladax Biomedical Inc. Gemcitabine immunoassay
US8771972B2 (en) * 2011-05-24 2014-07-08 Saladax Biomedical Inc. Clozapine immunoassay
US20120301973A1 (en) * 2011-05-24 2012-11-29 Salamone Salvatore J Clozapine immunoassay
WO2012167255A1 (en) * 2011-06-03 2012-12-06 The Regents Of The University Of Colorado, A Body Corporate Anticancer prodrug therapies
US10782308B2 (en) 2012-07-16 2020-09-22 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Direct reading detection kits for surface contamination by antineoplastic drugs
EP2922818B1 (en) 2012-11-24 2018-09-05 Hangzhou Dac Biotech Co., Ltd Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
AU2014384434B2 (en) 2014-02-28 2016-11-03 Hangzhou Dac Biotech Co., Ltd Charged linkers and their uses for conjugation
WO2016026916A2 (en) * 2014-08-19 2016-02-25 Ecole Polytechnique Federale De Lausanne (Epfl) Phase transfer based chemical sensing
NZ739830A (en) 2015-07-12 2021-12-24 Hangzhou Dac Biotech Co Ltd Bridge linkers for conjugation of cell-binding molecules
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
KR102345175B1 (ko) 2016-11-14 2021-12-31 항저우 디에이씨 바이오테크 씨오, 엘티디 결합 링커, 그러한 결합 링커를 함유하는 세포 결합 분자-약물 결합체, 링커를 갖는 그러한 결합체의 제조 및 사용
CN114149474B (zh) * 2020-09-08 2024-03-19 鲁南制药集团股份有限公司 一种4’-表柔红霉素的中间体化合物及其制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996344A (en) 1972-05-15 1976-12-07 Biological Developments, Inc. Phenethylamine antigenic conjugates, their preparation, antibodies and use
US4016146A (en) 1974-12-10 1977-04-05 Biological Developments, Inc. Phenethylamine antigenic conjugates, their preparation, antibodies, and use
US4269511A (en) 1979-02-15 1981-05-26 Abbott Laboratories Apparatus and method for measuring the magnitude of polarization of light
US4420568A (en) 1980-07-30 1983-12-13 Abbott Laboratories Fluorescent polarization immunoassay utilizing substituted triazinylaminofluoresceins
IT1223136B (it) * 1987-11-17 1990-09-12 Ist Naz Stud Cura Dei Tumori Anticorpi monoclonali capaci di legarsi selettivamente alla doxorubicina ed analoghi e derivati
US4990443A (en) * 1988-01-25 1991-02-05 Boehringer Mannheim Gmbh Hapten-protein conjugates and methods of use in immunoassays
IL106992A (en) 1988-02-11 1994-06-24 Bristol Myers Squibb Co Acylhydrazone derivatives of anthracycline and methods for their preparation
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5101015A (en) 1989-04-10 1992-03-31 Abbott Laboratories Reagents for an amphetamine-class fluorescence polarization immunoassay
IT1238675B (it) 1990-01-26 1993-09-01 Ist Naz Stud Cura Dei Tumori Anticorpo monoclonale in grado di riconoscere uno specifico epitopo di glicosidi antraciclinici e ibridoma secernente tale anticorpo
US5622929A (en) * 1992-01-23 1997-04-22 Bristol-Myers Squibb Company Thioether conjugates
CA2096495C (en) 1992-06-16 2002-07-09 Kathy Palmer Ordonez Dual analyte immunoassay
US20020119095A1 (en) * 1992-07-10 2002-08-29 Reinhard Gabathuler Chemotherapeutic agents conjugated to p97 and their methods of use in treating neurological tumours
AU670108B2 (en) * 1992-09-11 1996-07-04 Becton Dickinson & Company Improved antibodies to plasmodium falciparum
DE4236237A1 (de) 1992-10-27 1994-04-28 Behringwerke Ag Prodrugs, ihre Herstellung und Verwendung als Arzneimittel
AU1140495A (en) * 1994-01-27 1995-08-03 Bristol-Myers Squibb Company Method for preparing thioether conjugates
DK0871490T3 (da) * 1995-12-22 2003-07-07 Bristol Myers Squibb Co Forgrenede hydrazonlinkere
WO2002013843A2 (en) * 2000-08-17 2002-02-21 University Of British Columbia Chemotherapeutic agents conjugated to p97 and their methods of use in treating neurological tumours
US7678551B2 (en) * 2004-10-25 2010-03-16 Seradyn, Inc. Immunoassays for lamotrigine
CA2602849C (en) * 2005-03-30 2013-06-04 Saladax Biomedical Inc. Doxorubicin immunoassay

Similar Documents

Publication Publication Date Title
JP2008537110A5 (enExample)
JP2008530528A5 (enExample)
CA2790508A1 (en) Lenalidomide and thalidomide immunoassays
JP2008534927A5 (enExample)
US7179659B2 (en) Sensor surfaces for detecting analytes and methods of use
CN101495867B (zh) 聚合物骨架元素标签
JP4255514B2 (ja) 疎水性の立体配座制限的微細環境を提供する部分によって強化された重合フルオロホア
Torres et al. Characterization and optimization of heroin hapten-BSA conjugates: method development for the synthesis of reproducible hapten-based vaccines
JPH05502515A (ja) 多目的バインディングフィルム
EP0674178A3 (en) Cyclosporin immunoassay.
Gomara et al. Assessment of synthetic peptides for hepatitis A diagnosis using biosensor technology
JP2011506973A5 (enExample)
Zhang et al. Polymeric dipicolylamine based mass tags for mass cytometry
JP2005106609A5 (enExample)
ES2197214T3 (es) Agentes entrecruzants, conjugantes y reductores activados por fosfatasa; procedimientos de utilizacion de estos agentes y reactivos que comprenden estos agentes.
CN107353200A (zh) 一种香草扁桃酸衍生物、其合成方法及一种香草扁桃酸免疫原、其制备方法及其应用
CN102288763B (zh) 一种基于量子点的免疫荧光检测莱克多巴胺的方法及专用试剂盒
WO2004060915A3 (en) Prostate specific antigens, conjugates thereof, methods for their preparation and uses thereof.
KR970705024A (ko) 마커그룹 및 햅텐이 선택적으로 혼입된 올리고머 담체 분자
Yao et al. NHS-ester functionalized poly (PEGMA) brushes on silicon surface for covalent protein immobilization
JP2004538447A5 (enExample)
CN102295698B (zh) 环孢霉素a免疫原、特异性抗体、检测试剂及检测试剂盒
AU2003239048B2 (en) Coated metal surface on solid support useful in analyte detection by displacement
EP1798250A2 (en) Molecules suitable for binding to a metal layer for covalently immobilizing biomolecules
CN105238388B (zh) 一种用于细胞内糖链抗原活检的双光子荧光探针、荧标试剂盒以及检测方法